Joshua Aiello's most recent trade in Orchestra BioMed Holdings Inc was a trade of 241 Common Stock, par value $0.0001 per share ("Common Stock") done at an average price of $4.6 . Disclosure was reported to the exchange on March 25, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Orchestra BioMed Holdings Inc | Joshua Aiello | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.57 per share. | 25 Mar 2026 | 241 | 18,644 | - | 4.6 | 1,101 | Common Stock, par value $0.0001 per share ("Common Stock") |
| Orchestra BioMed Holdings Inc | Joshua Aiello | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Orchestra BioMed Holdings Inc | Joshua Aiello | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.31 per share. | 02 Jan 2026 | 241 | 18,885 | - | 4.3 | 1,039 | Common Stock, par value $0.0001 per share ("Common Stock") |
| Orchestra BioMed Holdings Inc | Joshua Aiello | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.46 per share. | 17 Sep 2025 | 203 | 19,126 | - | 2.5 | 499 | Common Stock, par value $0.0001 per share ("Common Stock") |
| Orchestra BioMed Holdings Inc | Joshua Aiello | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2025 | 15,000 | 19,329 | - | 0 | Common Stock, par value $0.0001 per share ("Common Stock") | |
| Orchestra BioMed Holdings Inc | Joshua Aiello | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.99 per share. | 18 Jun 2025 | 393 | 4,329 | - | 3.0 | 1,175 | Common Stock, par value $0.0001 per share ("Common Stock") |
| Orchestra BioMed Holdings Inc | Joshua Aiello | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2025 | 48,000 | 48,000 | - | - | Stock Option (Right to Buy) | |
| Orchestra BioMed Holdings Inc | Joshua Aiello | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.38 per share. | 26 Mar 2025 | 278 | 4,722 | - | 4.4 | 1,218 | Common Stock, par value $0.0001 per share |
| Orchestra BioMed Holdings Inc | Joshua Aiello | Principal Accounting Officer | 08 May 2024 | 42,000 | 42,000 | - | - | Stock Option (Right to Buy) | ||
| Orchestra BioMed Holdings Inc | Joshua Aiello | Principal Accounting Officer | 20 Jul 2023 | 7,500 | 7,500 | - | - | Stock Option (Right to Buy) | ||
| Orchestra BioMed Holdings Inc | Joshua Aiello | Principal Accounting Officer | 20 Jul 2023 | 5,000 | 5,000 | - | 0 | Common Stock, par value $0.0001 per share ("Common Stock") | ||
| Orchestra BioMed Holdings Inc | Joshua Aiello | Principal Accounting Officer | 26 Jan 2023 | 18,228 | 18,228 | - | - | Nonstatutory Stock Option (Right to Buy) |